Integrative pipeline to profile and target endocrine therapy-insensitive cell populations in ER+ breast cancer
Svetlana E. Semina, Rosemary J. Huggins, Huiping Zhao, Keiko Yanagihara, Monica Sheinin, Virgilia Macias, Fouad Alani, Leo Feferman, Andre Kajdacsy‐Balla, Debra A. Tonetti, Kent F. Hoskins, Geoffrey L. Greene, Jonna M. Frasor, Jonathan L. Coloff
The paper develops an analytical pipeline to identify and target endocrine therapy-insensitive cells in ER+ breast cancer using single-cell RNA sequencing and functional validation in organoid models.
bioRxiv · Sep 16, 2026 · PreprintCancer Biology